REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 104 filers reported holding REGULUS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $131,000 | -27.2% | 79,643 | -0.3% | 0.00% | – |
| Q4 2016 | $180,000 | -33.6% | 79,843 | -2.8% | 0.00% | -100.0% |
| Q3 2016 | $271,000 | +15.3% | 82,143 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $235,000 | -43.4% | 81,343 | +35.8% | 0.00% | 0.0% |
| Q1 2016 | $415,000 | -9.2% | 59,890 | +14.2% | 0.00% | 0.0% |
| Q4 2015 | $457,000 | +35.6% | 52,450 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $337,000 | -40.5% | 51,464 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $566,000 | +18.9% | 51,664 | +83.7% | 0.00% | 0.0% |
| Q1 2015 | $476,000 | +3.7% | 28,125 | -1.7% | 0.00% | 0.0% |
| Q4 2014 | $459,000 | +166.9% | 28,625 | +13.5% | 0.00% | – |
| Q3 2014 | $172,000 | -14.9% | 25,217 | +0.6% | 0.00% | -100.0% |
| Q2 2014 | $202,000 | +22.4% | 25,073 | +37.2% | 0.00% | – |
| Q1 2014 | $165,000 | +22.2% | 18,273 | 0.0% | 0.00% | – |
| Q4 2013 | $135,000 | -21.5% | 18,273 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $172,000 | +12.4% | 18,273 | +17.3% | 0.00% | – |
| Q2 2013 | $153,000 | -12.1% | 15,573 | -30.8% | 0.00% | -100.0% |
| Q1 2013 | $174,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|